Contemporaneous Measurement of Outer and Inner Membrane Permeability in Gram-negative Bacteria.

Antimicrobial peptides Gram-negative bacteria N-phenyl-1-naphthylamine Outer and inner membrane permeability Propidium iodide

Journal

Bio-protocol
ISSN: 2331-8325
Titre abrégé: Bio Protoc
Pays: United States
ID NLM: 101635102

Informations de publication

Date de publication:
05 Mar 2020
Historique:
received: 07 11 2019
revised: 15 01 2020
accepted: 17 01 2020
pmc-release: 05 03 2021
entrez: 4 3 2021
pubmed: 5 3 2021
medline: 5 3 2021
Statut: epublish

Résumé

The emergence and rapid spread of multidrug resistance in bacteria have led to the urgent need for novel antibacterial agents. Membrane permeabilization is the mechanism for many antibacterial molecules that are being developed against gram-negative bacteria. Thus, to determine the efficacy of a potential antibacterial molecule, it is important to assess the change in bacterial membrane permeability after treatment. This study describes the protocol for the assays of outer and inner membrane permeability using the fluorescent probes N-phenyl-1-naphthylamine and propidium iodide. Compared with other experiments, such as electron microscopy and the assay of minimal bactericidal concentration, this methodology provides a simpler, faster, and cost-effective way of estimating the membrane-permeabilizing effect and bactericidal efficacy of antibacterial molecules. This study presents an optimized protocol with respect to the classical protocols by incubating bacteria with antibacterial molecules in the culture condition identical to that of antibacterial assays and then detecting the signal of the fluorescent probe in the buffer without broth and antibacterial molecules. This protocol avoids the effect of nutrient deficiency on the physiological status of bacteria and the interference of antibacterial molecules towards the fluorescent probe. Thus, this method can effectively and precisely evaluate the membrane permeability and match the results obtained from other antibacterial assays, such as minimum inhibitory concentration and time-kill curve assays.

Identifiants

pubmed: 33659522
doi: 10.21769/BioProtoc.3548
pii: e3548
pmc: PMC7842588
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e3548

Informations de copyright

Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no conflict of interest.

Références

Biomaterials. 2016 May;87:32-45
pubmed: 26897538
Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1221-5
pubmed: 8577744
ACS Infect Dis. 2016 Feb 12;2(2):132-9
pubmed: 27624964
Nat Commun. 2019 Aug 6;10(1):3517
pubmed: 31388008
Infect Drug Resist. 2019 May 27;12:1393-1405
pubmed: 31239720
Antimicrob Agents Chemother. 2016 Jun 20;60(7):4283-9
pubmed: 27161645

Auteurs

Bo Ma (B)

Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.

Chao Fang (C)

Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.

Jing Zhang (J)

Department of Nephroloy and Endocrinology, No. 371 Central Hospital of People's Liberation Army, Xinxiang, Henan, China.

Mingzhi Wang (M)

Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.

Xiaoxing Luo (X)

Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.

Zheng Hou (Z)

Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.

Classifications MeSH